Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke

August 31, 2008

An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.

Dr. Salim Yusuf and Dr. Koon Teo, professors in the Michael G. DeGroote School of Medicine at McMaster University and clinicians at Hamilton Health Sciences, led the study. Today the research results will be published online by The Lancet and presented at this year's European Society of Cardiology Congress in Munich, Germany.

ACE inhibitors, or angiotensin-converting-enzyme inhibitors, are widely used and effective medications used to lower blood pressure. They work by helping to widen blood vessels to improve blood flow. Approximately 20 per cent of patients who could benefit from an ACE inhibitor stop taking it because of cough, kidney problems, swelling or symptomatic low blood pressure.

Telmisartan is a type of angiotensin-receptor blocker, or ARB. Like ACE inhibitors, telmisartan also lowers blood pressure, but works in a different manner. ARBs block the receptor sites in the body for angiotensin II, a naturally occurring hormone that constricts blood vessels and increases blood pressure.

The TRANSCEND (Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease) study enrolled nearly 6,000 people worldwide who are intolerant to ACE inhibitors, and evaluated whether telmisartan — compared to placebo — would reduce the risk of major cardiovascular events. A high proportion of patients received proven therapies, such as statins, anti-platelet agents and beta-blockers. Physicians were also free to use other medications that could lower blood pressure.

The researchers found that the outcome of cardiovascular death, heart attack or stroke was modestly reduced when patients took telmisartan. In addition, fewer patients receiving telmisartan were hospitalized for any cardiovascular reason compared to placebo. Telmisartan was also remarkably well tolerated, and fewer patients on telmisartan discontinued the medication compared to placebo.

Telmisartan reduced the outcome of cardiovascular death, heart attack, stroke or hospitalization for heart failure by a relative eight per cent (17 per cent in the placebo experienced those cardiac events compared to 15.8 per cent in the telmisartan group). This difference was not statistically significant.

However, when the outcome included cardiovascular death, heart attack or stroke (and not hospitalization for heart failure), telmisartan reduced that outcome by a significant 13 per cent (14.8 per cent in the placebo group experienced those cardiac events compared to 13 per cent with telmisartan).

"The TRANSCEND study demonstrates the value of telmisartan in people who are unable to tolerate angiotensin converting enzyme inhibitors," said principal investigator Dr. Yusuf, director of the Population Health Research Institute at McMaster University.

"Although the benefit is of moderate size, there is an impact on a range of outcomes including the composite of cardiovascular death, myocardial infarction and strokes, as well as cardiovascular hospitalizations. Given the large proportion of people who are unable to tolerate an ACE inhibitor, the use of telmisartan would be clinically important."

Source: McMaster University

3.5 /5 (4 votes)  

Rank 3.5 /5 (4 votes)
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

New ability to regrow blood vessels holds promise for treatment of heart disease

(Medical Xpress) -- University of Texas at Austin researchers have demonstrated a new and more effective method for regrowing blood vessels in the heart and limbs — a research advancement that could have ...

Medicine & Health / Research

created 57 minutes ago | popularity 5 / 5 (3) | comments 0 | with audio podcast

Motivation to exercise affects behavior

(Medical Xpress) -- For many people, the motivation to exercise fluctuates from week to week, and these fluctuations predict whether they will be physically active, according to researchers at Penn State. In an effort to ...

Medicine & Health / Health

created 47 minutes ago | popularity not rated yet | comments 0 | with audio podcast

'It's not nutritious until it's eaten'

As part of her "Let's Move! Initiative," First Lady Michelle Obama unveiled a new web resource highlighting new changes in the Chefs Move to Schools, during a CMST gathering in Dallas, TX today. CMTS advocates ...

Medicine & Health / Health

created 34 minutes ago | popularity not rated yet | comments 0

New tumor suppressor gene identified

A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...

Medicine & Health / Cancer

created 1 hour ago | popularity 4.7 / 5 (3) | comments 0

Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you

(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...

Medicine & Health / Psychology & Psychiatry

created 3 hours ago | popularity 4.5 / 5 (2) | comments 0


Fast photon control brings quantum photonic technologies closer

(PhysOrg.com) -- Using photons instead of electrons to transmit information could lead to faster and more secure ways to communicate, among other advantages. Now a team of physicists has taken another step toward realizing ...

Planck mission steps closer to the cosmic blueprint

(PhysOrg.com) -- ESA's Planck mission has revealed that our Galaxy contains previously undiscovered islands of cold gas and a mysterious haze of microwaves. These results give scientists new treasure to mine ...

A lost world? How zooarchaeology can inform biodiversity conservation

A new study of tropical forests will provide a 50,000-year perspective on how animal biodiversity has changed, explored through an archaeological investigation of animal bones.

Myths and shame keep many from seeking bankruptcy protection

(PhysOrg.com) -- Two interesting facts that may counter modern ideas about bankruptcy: The overwhelming majority of U.S. filings belong to individuals rather than corporations or entities, and most of these ...

Big Society could threaten biodiversity conservation

A study of the Moray Firth Seal Management Plan (MFSMP), in north-east Scotland, identified four key conditions for long-term success, three of which pointed to the importance of direct government involvement.

Independent group inspects Apple supplier

(AP) -- An independent group, the Fair Labor Association, has started auditing Apple Inc.'s Chinese supplier Foxconn after a request by Apple.